Govt issues guidelines on GLP-1 Drugs' use, risks, and regualtions

Apr 01, 2026

The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release.

Mayim Bialik reveals severe side effects after single GLP-1 dose

Jun 06, 2026

According to PEOPLE magazine, in an essay published in a U.S.-based digital news outlet, Bialik shared why she decided to try the medication and...

GLP-1 should not be used as a quick fix for weight loss and diabetes management, warns top experts

Mar 30, 2026

Top medical experts are raising urgent alarms against using GLP-1 as a lifestyle enhancer, highlighting the risk of shortages for high-risk patients.

Drug regulator inspects 49 entities over unauthorised sale of weight loss drugs

Mar 24, 2026

India's drug regulator has intensified monitoring of the supply chain of GLP-1-based weight loss drugs amid concerns over their unauthorised sale and misuse.

Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trial

Apr 18, 2025

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food...

NoGuilt Fitness Launches Fitty GLP-1 Daily: a Clinical Solution for Healthy Weight Loss and Sugar Balance

Oct 24, 2025

Chandigarh [India], October 24: NoGuilt Fitness, a homegrown health and wellness company focused on sustainable transformation, has launched Fitty GLP-1 Daily, a science-backed supplement...